bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.02.08.704625

bMINTY: Enabling Reproducible Management of High-Throughput Sequencing Analysis Results and their Metadata

Abstract

Due to the large scale of high-throughput sequencing data generation, the community and publishers have established standards for the dissemination of studies that produce and analyze these data. Despite efforts towards Findable, Accessible, Interoperable and Reproducible (FAIR) science, critical obstacles remain. Best practices are not consistently enforced by scientific publishers, and when they are, essential information is fragmented across the methods section, supplementary materials, and public repositories. When attempting to reproduce scientific findings or reuse published data or analyses, researchers often avoid analyzing sequencing data from the ground up. Instead, they prefer to start directly from the post-sequence-alignment information (e.g., gene expression matrices in transcriptomics). However, existing repositories and workflow-oriented solutions rarely provide a single, portable, queryable resource that integrates this information with the metadata required for downstream reuse. We introduce bMINTY, a locally deployed web application with an intuitive user interface, for structured management of post-alignment workflow data outputs. bMINTY supports metadata for studies, assays, and analysis assets, including workflows, genome assemblies, genomic intervals, and cell-level entities for single-cell assays. Users may export query results in RO-Crate format, providing machine readable data packages and metadata. To the best of current knowledge, bMINTY is the first framework to bundle all this information in publication-ready, portable packaging designed for reuse. These packages can be included as supplementary material with each publication, accompanied by analysis code deposited in public repositories for downstream ad hoc analyses. Together, these practices can promote transparency, efficient reuse of published data, and support FAIR-aligned scientific reproducibility.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kapelios, K., Xiropotamos, P., Manousaki, H., Sinnis, C., Kotsira, V., Dalamagas, T., GEORGAKILAS, G. K.. 2026-02-10. bMINTY: Enabling Reproducible Management of High-Throughput Sequencing Analysis Results and their Metadata. https://doi.org/10.64898/2026.02.08.704625

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗